Surgery or Noninvasive Therapy for Varicose Veins - Full Text View

Purpose

For more than 100 years, surgery has been the standard of care of varicose veins of the legs. The down side of surgery is that it requires anesthesia, leaves scars, and has a relatively high recurrence rate in the long term (up to 40%). In the last decade, several new techniques have become available but they have not yet been compared to surgery. This trail will evaluate the effectiveness, patients` perspective and cost effectiveness of surgery and non-invasive techniques such as ultrasound guided sclerocompression therapy and endovenous laser therapy.

Condition	Intervention	Phase
Varicose Vein	Procedure: crossectomie and short stripping Procedure: ultrasound guided sclerocompression therapy Procedure: endovenous laser therapy	Phase III

MedlinePlus related topics:

Ultrasound Varicose Veins

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study

Official Title:	Randomized Unicenter Comparative Study of the Treatment of Insufficient Greater Saphenous Vein: Surgery vs Ultrasound Guided Sclerocompression Therapy With Foam and Endovenous Laser Therapy

Further study details as provided by Erasmus Medical Center:

Primary Outcome Measures:

anatomical succes rate (absence or obliteration of GSV on US examination) [ Time Frame: 3 months, 1 and 5 years ]

Secondary Outcome Measures:

treatment realted adverse events and complications [ Time Frame: 3 months, 1 and 5 years ]
patient reported outcomes (HRQOL and treatment satisfaction) [ Time Frame: 3 months, 1 and 5 years ]
cost effectiveness analysis [ Time Frame: 3 months, 1 and 5 years ]

Estimated Enrollment:	240
Study Start Date:	May 2007
Estimated Study Completion Date:	May 2011

Arms	Assigned Interventions
1: Active Comparator Surgery: crossectomie plus short stripping	Procedure: crossectomie and short stripping under spinal or complete anaesthesia
2: Active Comparator ultrasound guided sclerocompression therapy with foam (3% polidaconal)	Procedure: ultrasound guided sclerocompression therapy 1 part 3% polidocanol mixed with 3 parts of air. Between 3cc - 12 cc per varicose vein>
3: Active Comparator Endovenous laser therapy (940 nm, about 70 J/cm)	Procedure: endovenous laser therapy 940 nm Diode laser. About 70 J/cm will be administered. Disposables from Angiocare will be used.

Show Detailed Description

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

primary insufficient GSV objectived with US: reflux>0.5 sec and diameter>0.5cm)
non-treated varicose veins
>18 years
informed consent

Exclusion Criteria:

acute thrombosis or flebitis
agnesia of deep venous system
vascular syndromes
use of anticoagulantia
contraindications surgery

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00529672

Contacts


Contact: Michael Kockaert, MD	31 10 4634580	M.KOCKAERT@ERASMUSMC.NL

Contact: Tamar Nijsten, MD, PhD	31 10 4631019	t.nijsten@erasmusmc.nl

Locations


Netherlands
	Erasmus MC dermatology	Recruiting
	Rotterdam, Netherlands, 3000 CA
	Contact: Michael Kockaert, MD 31 10 4634580 m.kockaert@erasmusmc.nl
	Contact: Tamar Nijsten, MD, PhD 31 10 4631019 t.nijsten@ersmusmc.nl
	Sub-Investigator: Prof. sambeek, MD, PhD

Sponsors and Collaborators

Erasmus Medical Center

Investigators


Principal Investigator:	Martino Neumann, MD, PhD	Erasmus MC

More Information

Study ID Numbers:	2005-325
First Received:	September 13, 2007
Last Updated:	September 17, 2007
ClinicalTrials.gov Identifier:	NCT00529672
Health Authority:	Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Erasmus Medical Center:

endovenous laser thearpy

sclerocompression therapy

crossectomie and stripping

surgery

treatment

varicose veins

Study placed in the following topic categories:

Varicose Veins

Vascular Diseases

Polidocanol

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 10, 2008

Sponsored by:	Erasmus Medical Center
Information provided by:	Erasmus Medical Center
ClinicalTrials.gov Identifier:	NCT00529672